# CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE
> **ANDA218273** · Abbreviated New Drug Application (Generic) · Sponsor: COSETTE PHARMS NC · Approved 2025-11-10
## Drug
- **FDA Application Number:** ANDA218273
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE
- **Generic name:** CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE
- **Active ingredients:** CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OTIC
- **Marketing status:** Prescription
- **Sponsor:** COSETTE PHARMS NC
- **Manufacturer:** Cosette Pharmaceuticals, Inc.
- **First approval:** 2025-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218273)
---
*AI Analytics · CC0 1.0*